Recent Rosacea Blog Posts

Solodyn with and without Finacea

A recent study has highlighted the benefits of the combination therapy of Solodyn and Finacea. Solodyn is one of the lesser known systemic rosacea treatments. What is Solodyn? Solodyn is an extended-release, low dosage of Minocycline, a member of the tetracycline family. Solodyn is available in 8 strengths. Yes that is right you can get […]

Continue Reading

A slightly obscure clinical trial has recently listed, related to treating the lesions and facial blood vessels of rosacea. The drug mentioned is PDI-320, and the party conducting the trial is Precision Dermatology. What is PDI-320? If you look closely at the exclusion criteria, you see that participants are not allowed to have  “previously failed […]

Continue Reading

Foamix Minocycline Foam works for Bacterial Infections

A recent press release teases rosacea sufferers that a topical foaming form of minocycline might become a new treatment. The trial results promoted in the press release are for a condition called Impetigo, a bacterial skin infection. Minocycline, as a member of the tetracycline family may offer some anti-inflammatory benefit to rosacea sufferers, but the […]

Continue Reading

Lupin and Medicis Agree Over Generic Solodyn

In contrast to the ongoing disputes over generic Oracea, the makers of the low-dose minocycline Solodyn, Medicis have entered into a joint development and sales agreement with Lupin Pharmaceuticals. Solodyn is a form of Minocycline, a member of the tetracycline famaily, available in 8 strengths, prescribed based primarily on your weight. Solodyn tablets are available […]

Continue Reading

Mylan continues to fight for Generic Oracea

Documents recently filed in the Mylan vs. Galderma patent litigation reveal that Mylan Pharmaceuticals continues to argue that it should be allowed to manufacture generic Oracea. This ongoing battle is known as the “Oracea Patent Litigation”. If you are interested to see how generic pharma takes on big pharma to get a bite of the […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.